Funds Highlight Limitations of Systematic Products
Aug 2, 2015
Systematic products are not a catch all solution and should not replace “good ol’ fashioned view taking,” with buyside hedge fund participants noting numerous inherent problems in an overcrowded market.
Restricted content
You must be an EQD+ subscriber to view this page. Either sign in or see below on how to request a trial.
Get access now
Start your 7 day free trial.
You’ll be charged at the conclusion of your trial.
Cancel at any time.
Questions? Need access for multiple users?
Contact eqdplus@eqderivatives.com